INS and polycystic ovary syndrome: We have previously shown that in adolescent girls with PCOS, oral contraception (OC)—as compared to combined low-dose insulin sensitization plus antiandrogen therapy—is linked to a less favorable endocrine-metabolic profile [5, 6].